Lupin Ltd NSE:LUPIN:LUPIN - ANNOUNCES EMA APPROVAL FOR NAMUSCLA PEDIATRIC INDICATION
RE Reuters Lupin Announces EMA Approval For Namuscla Pediatric Indication 7/1/2026, 08:25 PM GMT+8 Reuters LU LUPIN Lupin Ltd NSE:LUPIN: Lupin Ltd NSE:LUPIN:LUPIN - ANNOUNCES EMA APPROVAL FOR NAMUSCLA PEDIATRIC INDICATION Market News CNBC TV18 Lupin gets EU approval to expand rare disease drug NaMuscla to children Reuters Lupin Announces EMA Approval For Namuscla Moneycontrol Lupin gains after USFDA grants tentative approval for Enzalutamide tablets